Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
Everyone will burn if exposed to enough ultraviolet radiation from the sun or other sources. However, some people burn particularly easily or develop exaggerated skin reactions to sunlight. Doctors call this condition photosensitivity. For some people, consuming certain medications or plant products—or rubbing them on their skin—can cause photosensitivity. Similar reactions are seen in diseases such as some forms of porphyria (a group of usually hereditary metabolic disorders) or lupus. In another condition, called polymorphous light eruptions (PLEs), dramatic rashes can develop after fairly limited sun exposure.
The most important step toward treating photosensitivity is to identify whether an external substance is causing the reaction, and then eliminate it if possible. Antibiotics are among the most common photosensitizing drugs. Many other natural substances can also cause this reaction. Another commonsense step is to use sunscreen and wear protective clothing, or simply to stay out of the sun.
Some types of photosensitivity may respond to specific treatments such as oral beta-carotene, steroids, or other medications.
Beta-carotene, a plant pigment giving color to carrots and yams, may be beneficial for at least two kinds of photosensitivity: PLEs 6,7 and photosensitivity caused by certain types of porphyria.8-10 It is the best-studied supplement for photosensitivity, although only four studies on it have been placebo-controlled, and these had conflicting results.11-13 According to one theory, beta-carotene prevents skin damage by neutralizing free radicals, harmful chemicals created in the skin by the action of radiation.14
One characteristic of beta-carotene is that it gives a deep yellow color to human skin when taken in high doses for several months. Since supplementation must go on for a while to see results, this side effect makes it difficult to conduct a truly double-blind study in which neither researchers nor the participants know who is taking the active compound and who is taking placebo. (For reasons why double-blinding is so important, see Why Does This Database Rely on Double-blind Studies?) Once people begin to turn yellow, they are likely to figure out what they're taking, possibly affecting the study outcome. Therefore, even the results of placebo-controlled studies of beta-carotene are open to question.
That said, three controlled trials of beta-carotene for polymorphous light eruptions found mixed results. A 10-week study in 50 people with PLE given beta-carotene plus canthaxanthin (another carotene) or placebo found evidence of significant benefit.15 However, in two other controlled trials of beta-carotene alone, lasting 12 to 15 weeks (the number of participants was not reported), modest benefits were seen in one study and no benefits at all in the other.16
Many uncontrolled studies have reported that beta-carotene extends the time that people with erythropoietic protoporphyria (EPP) can safely spend in the sun.17-19 However, studies that lack a control group, as these did, are notorious for producing over-optimistic results, and an 11-month controlled trial found no benefit.20 A few case reports suggest beta-carotene may also be helpful in another kind of porphyria called porphyria cutanea tarda.21
For more information, including dosage and safety issues, see the full Beta-carotene article.
Many, though not all, studies suggest that various antioxidant substances, including chocolate, vitamin C, lycopene, mixed carotenoids, flavonol-enriched green tea extracts, vitamin E, and zeaxanthin taken orally or used topically may help prevent sunburn in people without photosensitivity.22-25,43-49,51-59
On this basis, a variety of antioxidants have been tried for photosensitivity as well. In a double-blind, placebo-controlled trial of 12 people with EPP, 1 g of vitamin C taken orally daily appeared to help reduce symptoms.38 However, the study was too small for the results to be statistically significant.
A small double-blind, placebo-controlled trial of individuals with PLE found no benefit with combined vitamin C (3 g per day) and vitamin E (1,500 IU per day).42
In an uncontrolled study of adenosine monophosphate (AMP) in 21 people with porphyria cutanea tarda, many participants showed decreased photosensitivity, much to the surprise of the investigator.39
Two cases of EPP were also reportedly improved by vitamin B6.40 In addition, nicotinamide —another B vitamin—was found to help prevent polymorphous light eruptions in an uncontrolled (and, therefore, highly unreliable) study of 42 people.41
A number of common herbs and plant products are known to provoke extreme reactions to sunlight in some individuals. One of the more well-known culprits is St. John's wort, which has caused fatal photosensitivity reactions in cattle that grazed on it. In one study of highly sun-sensitive people, double doses of the herb produced mild increases in reaction to ultraviolet radiation.1 There is also one report of a severe skin reaction in an individual who used St. John's wort and then received ultraviolet therapy for psoriasis.2 In addition, topical St. John's wort apparently caused severe sunburn in one individual.3 For this reason, photosensitive people should probably avoid St. John's wort.
Photosensitivity can also result from touching or eating other plants, including celery, dill, fennel, fig, lime, parsley, and parsnip, as well as arnica, artichoke, chrysanthemum, dandelion, lettuce, endive, marigold, and sunflower.4,5 Lest you swear off gardening or salads altogether, be aware that most people do not react to these plants. Essential oils of plants may be more problematic than the whole plant itself.
1. Brockmoller J, Reum T, Bauer S, et al. Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry. 1997;30(suppl) 2:94-101.
2. Lane-Brown MM. Photosensitivity associated with herbal preparations of St John's wort ( Hypericum perforatum) [letter]. Med J Aust. 2000;172:302.
3. Lane-Brown MM. Photosensitivity associated with herbal preparations of St John's wort ( Hypericum perforatum) [letter]. Med J Aust. 2000;172:302.
4. Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol. 1995;33:551-573.
5. Potter TS, Hashimoto K. Cutaneous photosensitivity to medications. Compr Ther. 1994;20:414-417.
6. Suhonen R, Plosila M. The effect of beta-carotene in combination with canthaxanthin, Ro 8-8427 (Phenoro®), in treatment of polymorphous light eruptions. Dermatologica. 1981;163:172-176.
7. Corbett MF, Hawk JLM, Herxheimer A, et al. Controlled therapeutic trials in polymorphic light eruption. Br J Dermato. 1982;107:571-581.
8. Mathews-Roth MM, Pathak MA, Fitzpatrick TB, et al. Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA. 1974;228:1004-1008.
9. Mathews-Roth MM. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases. Ann NY Acad Sci. 1993;691:127-138.
10. Krook G, Haeger-Aronsen B. Beta-carotene in the treatment of erythropoietic protoporphyria. A short review. Acta Derm Venereol Suppl (Stockh). 1982;100:125-129.
11. Suhonen R, Plosila M. The effect of beta-carotene in combination with canthaxanthin, Ro 8-8427 (Phenoro®), in treatment of polymorphous light eruptions. Dermatologica. 1981;163:172-176.
12. Corbett MF, Herxheimer A, Magnus IA, et al. The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial. Br J Dermatol. 1977;97:655-662.
13. Corbett MF, Hawk JLM, Herxheimer A, et al. Controlled therapeutic trials in polymorphic light eruption. Br J Dermatol. 1982;107:571-581.
14. Mathews-Roth MM. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases. Ann NY Acad Sci. 1993;691:127-138.
15. Suhonen R, Plosila M. The effect of beta-carotene in combination with canthaxanthin, Ro 8-8427 (Phenoro®), in treatment of polymorphous light eruptions. Dermatologica. 1981;163:172-176.
16. Corbett MF, Hawk JLM, Herxheimer A, et al. Controlled therapeutic trials in polymorphic light eruption. Br J Dermato. 1982;107:571-581.
17. Krook G, Haeger-Aronsen B. Beta-carotene in the treatment of erythropoietic protoporphyria. A short review. Acta Derm Venereol Suppl (Stockh). 1982;100:125-129.
18. Mathews-Roth MM, Pathak MA, Fitzpatrick TB, et al. Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA. 1974;228:1004-1008.
19. Mathews-Roth MM. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases. Ann NY Acad Sci. 1993;691:127-138.
20. Corbett MF, Herxheimer A, Magnus IA, et al. The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial. Br J Dermatol. 1977;97:655-662.
21. Mathews-Roth MM. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases. Ann NY Acad Sci. 1993;691:127-138.
22. Gollnick HPM, Hopfenmuller W, Hemmes C, et al. Systemic beta carotene plus topical UV sunscreen are an optimal protection against harmful effects of natural UV-sunlight: results of the Berlin-Eilath study. Eur J Dermatol. 1996;6:200-205.
23. Lee J, Jiang S, Levine N, et al. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc Soc Exp Biol Med. 2000;223:170-174.
24. Stahl W, Heinrich U, Jungmann H, et al. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am J Clin Nutr. 2000;71:795-798.
25. Mathews-Roth MM, Pathak MA, Parrish J, et al. A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. J Invest Dermatol. 1972;59:349-353.
26. Garmyn M, Ribaya-Mercado JD, Russel RM, et al. Effect of beta-carotene supplementation on the human sunburn reaction. Exp Dermatol. 1995;4:104-111.
27. Wolf C, Steiner A, Honigsmann H. Do oral carotenoids protect human skin against UV erythema, psoralen phototoxicity, and UV-induced DNA damage? J Invest Dermatol. 1988;90:55-57.
38. Boffa MJ, Ead RD, Reed P, et al. A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed. 1996;12:27-30.
39. Gajdos A. A.M.P in porphyria cutanea tarda [letter]. Lancet. 1974;1:163.
40. Ross JB, Moss MA. Relief of the photosensitivity of erythropoietic protoporphyria by pyridoxine. J Am Acad Dermatol. 1990;22(2 Pt 2):340-342.
41. Neumann R, Rappold E, Pohl-Markl H. Treatment of polymorphous light eruption with nicotinamide: a pilot study. Br J Dermatol. 1986;115:77-80.
42. Eberlein-Konig B, Fesq H, Abeck D, et al. Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol Photoimmunol Photomed. 2000;16:50-52.
43. Darr D, Combs S, Dunston S, et al. Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage. Br J Dermatol. 1992;127:247-253.
44. Darr D, Dunston S, Faust H, et al. Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. Acta Derm Venereol. 1996;76:264-268.
45. Trevithick JR, Shum DT, Redae S, et al. Reduction of sunburn damage to skin by topical application of vitamin E acetate following exposure to ultraviolet B radiation: effect of delaying application or of reducing concentration of vitamin E acetate applied. Scanning Microsc. 1993;7:1269-1281.
46. Trevithick JR, Xiong H, Lee S, et al. Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch Biochem Biophys. 1992;296:575-582.
47. Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol. 1998;38:45-48.
48. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med. 1998;25:1006-1012.
49. Werninghaus K, Meydani M, Bhawan J, et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol. 1994;130:1257-1261.
50. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med. 1998;25:1006-1012.
51. Katiyar SK, Elmets CA, Agarwal R, et al. Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol. 1995;62:855-861.
52. Katiyar SK, Matsui MS, Elmets CA, et al. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol. 1999;69:148-153.
53. Elmets CA, Singh D, Tubesing K, et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol. 2001;44:425-432.
54. Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg. 1999;125:1091-1098.
55. Stahl W, Heinrich U, Wiseman S, et al. Dietary tomato paste protects against ultraviolet light-induced erythema in humans. J Nutr. 2001;131:1449-1451.
56. Heinrich U, Gartner C, Wiebusch M, et al. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. J Nutr. 2003;133:98-101.
57. Greul AK, Grundmann JU, Heinrich F, et al. Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium, and proanthocyanidins. Skin Pharmacol and Appl Skin Physiol. 2002;15:307-315.
58. Heinrich U, Neukam K, Tronnier H, et al. Long-term ingestion of high flavanol cocoa provides photoprotection against UV-induced erythema and improves skin condition in women. J Nutr. 2006;136:1565-1569.
59. Palombo P, Fabrizi G, Ruocco V, et al. Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2007;20:199-210.
60. Reuter J, Huyke C, Casetti F, et al. Anti-inflammatory potential of a lipolotion containing coriander oil in the ultraviolet erythema test. J Dtsch Dermatol Ges. 2008 Mar 26.
Last reviewed December 2015 by EBSCO CAM Review Board Last Updated: 12/15/2015